MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21. - Wikidata - wikimedia - TriplyDB

MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.

MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.

http://www.wikidata.org/entity/Q37577935

about

Autophagy-Regulating microRNAs and Cancer MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17-92 cluster.MicroRNA-17-5p aggravates lipopolysaccharide-induced injury in nasal epithelial cells by targeting Smad7.Circular RNA circ-ITCH inhibits bladder cancer progression by sponging miR-17/miR-224 and regulating p21, PTEN expression.MicroRNA-425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma-derived growth factor.Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.Prognostic value of miR-17-5p in cancers: a meta-analysis.miR-17-3p Downregulates Mitochondrial Antioxidant Enzymes and Enhances the Radiosensitivity of Prostate Cancer Cells

P2860

Q33572337-9D17224D-6E90-440A-AD80-0E3AE2547EF7 Q41025694-3280E13E-4DCB-483A-8A79-A68ACAA63CFD Q47141937-CF141C05-16B5-429B-AD68-89FEB6918E9E Q47372880-B7249D6A-0937-4930-A912-E90742DC9B1C Q47587240-12D02CC1-9415-4537-8599-C4F25CDE2E2A Q49280996-AAD70DA1-133C-41F5-8F21-150343253B76 Q49548074-71C2ADC2-87A8-406F-9E43-8E1369439DEE Q52608472-15FFA217-3FE3-4FC3-978B-457201D43212 Q52638921-AFAC1F9E-A8C0-448C-B9EA-4F8891D93458 Q55334412-64E3CA36-2357-493E-B1A3-FBF9B0B80790 Q58766572-F07EF66C-4288-43D0-B7E5-094E67DDAC4C

P2860

MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.

http://www.wikidata.org/entity/Q37577935

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@en

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@nl

type

label

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@en

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@nl

prefLabel

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@en

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@nl

P1433

Q37577935-C929413B-1FE2-4B30-921E-BFEC8B8AA890

P1476

Q37577935-BA9EBA1A-601A-4F94-8CF9-BCD92A641906

P2093

Q37577935-0DA5FF06-3A7C-4BE0-82C2-F5641E19990A

Q37577935-2A4D2057-8CF6-44E8-A075-1C0AA9667E5D

Q37577935-4C334CB3-C863-4B33-8EDC-4C082B23D76D

Q37577935-57C93AA1-F3BD-4565-85E1-2FB222D16BAB

Q37577935-82D397F5-4593-438F-A5C5-2AAF4428D7D0

Q37577935-C208A3CB-0C7D-4C98-9BB4-852B59F3ADB0

Q37577935-D7CB8EA1-67CB-422A-8442-54AAF461E368

Q37577935-E79FB5CE-EEFF-41C3-B68D-44E9303BA501

P2860

Q37577935-015B2BFC-1832-41B2-8042-CBBA0A1F2E9C

Q37577935-17A7B152-F010-4EA2-8190-06AAAE8CC757

Q37577935-1D8EB53D-CDBA-48B8-8AA1-2215E711AC70

Q37577935-26BFEC32-7999-46B8-93F2-384D11E08D64

Q37577935-27C41D59-D911-43D7-82C8-A0551199A95F

Q37577935-29FA47D0-271B-4D89-B4C7-34BE31CCCE97

Q37577935-2CA4F416-BB09-43B5-BB66-BABC616058E5

Q37577935-2D03538D-19B3-4224-AC36-2F9915D4BD79

Q37577935-4A62898B-EBDE-4351-BA29-FCEE5011E8CF

Q37577935-58BAEC12-AFAC-4732-9AF9-6CCD5D044FE4

P304

Q37577935-1BB01649-F1D0-443D-9026-4F64B850EDA7

P31

Q37577935-F79E7E41-298A-4B78-981F-3F991037B69C

P356

Q37577935-1B5C25ED-44EA-4616-9B46-81EF72D9D5EA

P407

Q37577935-6531A782-6BF9-45D9-9B45-D373F26D9E02

P433

Q37577935-45C3CAEA-8525-445A-93EB-AACF86CEC499

P478

Q37577935-A7C5CAF5-E708-40F1-B6A0-F1EBED9E94AB

P577

Q37577935-D662859B-E112-4130-835E-D5B08C7AE49A

P698

Q37577935-061F2FB9-7C58-4381-ABD4-B7ABE24DAC63

P932

Q37577935-91F0CDB7-BB6A-4E88-B36E-9ACD7E8D218B

P356

P1433

Cancer Medicine

P1476

MiR-17-5p promotes cancer cell ...... al carcinoma by targeting p21.

@en

P2093

Chun Chen

http://www.w3.org/2001/XMLSchema#string

Congying Xie

http://www.w3.org/2001/XMLSchema#string

Huiyan Wang

http://www.w3.org/2001/XMLSchema#string

Jie Yang

http://www.w3.org/2001/XMLSchema#string

Raoying Xie

http://www.w3.org/2001/XMLSchema#string

Weichao Hao

http://www.w3.org/2001/XMLSchema#string

Yujuan Qin

http://www.w3.org/2001/XMLSchema#string

Zenghong Lu

http://www.w3.org/2001/XMLSchema#string

P2860

The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression

The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition

Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis

Tumorigenicity of the miR-17-92 cluster distilled

Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA

P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer

MicroRNA-directed cleavage of HOXB8 mRNA

miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion

The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells

P304

3489-3499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.863

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27774777

http://www.w3.org/2001/XMLSchema#string

P932

5224848

http://www.w3.org/2001/XMLSchema#string